Department of Public Health and Caring Sciences, Clinical Nutrition and Metabolism, Uppsala University, Uppsala, Sweden.
Department of Surgical Sciences, Radiology, Uppsala University, Uppsala, Sweden.
J Clin Endocrinol Metab. 2019 Dec 1;104(12):6207-6219. doi: 10.1210/jc.2019-00160.
Saturated fatty acid (SFA) vs polyunsaturated fatty acid (PUFA) may promote nonalcoholic fatty liver disease by yet unclear mechanisms.
To investigate if overeating SFA- and PUFA-enriched diets lead to differential liver fat accumulation in overweight and obese humans.
Double-blind randomized trial (LIPOGAIN-2). Overfeeding SFA vs PUFA for 8 weeks, followed by 4 weeks of caloric restriction.
General community.
Men and women who are overweight or have obesity (n = 61).
Muffins, high in either palm (SFA) or sunflower oil (PUFA), were added to the habitual diet.
Lean tissue mass (not reported here). Secondary and exploratory outcomes included liver and ectopic fat depots.
By design, body weight gain was similar in SFA (2.31 ± 1.38 kg) and PUFA (2.01 ± 1.90 kg) groups, P = 0.50. SFA markedly induced liver fat content (50% relative increase) along with liver enzymes and atherogenic serum lipids. In contrast, despite similar weight gain, PUFA did not increase liver fat or liver enzymes or cause any adverse effects on blood lipids. SFA had no differential effect on the accumulation of visceral fat, pancreas fat, or total body fat compared with PUFA. SFA consistently increased, whereas PUFA reduced circulating ceramides, changes that were moderately associated with liver fat changes and proposed markers of hepatic lipogenesis. The adverse metabolic effects of SFA were reversed by calorie restriction.
SFA markedly induces liver fat and serum ceramides, whereas dietary PUFA prevents liver fat accumulation and reduces ceramides and hyperlipidemia during excess energy intake and weight gain in overweight individuals.
饱和脂肪酸(SFA)与多不饱和脂肪酸(PUFA)可能通过尚未明确的机制促进非酒精性脂肪肝疾病。
研究过量摄入富含 SFA 和 PUFA 的饮食是否会导致超重和肥胖人群肝脏脂肪堆积的差异。
双盲随机试验(LIPOGAIN-2)。8 周内过度喂养 SFA 与 PUFA,然后进行 4 周的热量限制。
普通社区。
超重或肥胖的男性和女性(n=61)。
在习惯性饮食中添加富含棕榈(SFA)或葵花籽油(PUFA)的松饼。
瘦组织质量(此处未报告)。次要和探索性结果包括肝脏和异位脂肪沉积。
按设计,SFA 组(2.31±1.38kg)和 PUFA 组(2.01±1.90kg)的体重增加相似,P=0.50。SFA 显著诱导肝脏脂肪含量(相对增加 50%),同时伴有肝酶和动脉粥样硬化性血脂升高。相比之下,尽管体重增加相似,但 PUFA 并未增加肝脏脂肪或肝脏酶,也未对血脂产生任何不良影响。与 PUFA 相比,SFA 对内脏脂肪、胰腺脂肪或全身脂肪的积累没有差异影响。SFA 持续增加,而 PUFA 降低循环神经酰胺,这些变化与肝脏脂肪变化中度相关,并被提议作为肝脂肪生成的标志物。热量限制逆转了 SFA 的不良代谢作用。
SFA 显著诱导肝脏脂肪和血清神经酰胺增加,而饮食 PUFA 可防止超重个体在能量摄入和体重增加期间肝脏脂肪堆积,并降低神经酰胺和血脂异常。